-James F Holland Researcher Activity Profile

Research Author Detailed Information 

James F Holland Publication Rate By Year

James F Holland has published 1 paper(s) in 1949, 2 paper(s) in 1960, 2 paper(s) in 1961, 3 paper(s) in 1962, 1 paper(s) in 1963, 1 paper(s) in 1964, 1 paper(s) in 1965, 1 paper(s) in 1966, 1 paper(s) in 1967, 2 paper(s) in 1968, 1 paper(s) in 1970, 3 paper(s) in 1972, 4 paper(s) in 1973, 2 paper(s) in 1974, 1 paper(s) in 1976, 1 paper(s) in 1978, 1 paper(s) in 1979, 2 paper(s) in 1981, 1 paper(s) in 1982, 1 paper(s) in 2007, 2 paper(s) in 2008, for a total of 34 research publications in total.

James F Jf Holland Author Information

LAST NAME: holland

FIRST NAME: James F

INITIALS: jf

AFFILIATION:

Papers

James F Holland's Publication Record

1. Characterization of viral particles isolated from primary cultures of human breast cancer cells. Year Published: 2007
Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.
2. Pancytopenia from mesantoin; report of two cases. Year Published: 1949
3. Active immunotherapy in leukemia with neuraminidase-modified leukemic cells. Year Published: 1978
4. Adjuvant therapy of operable primary osteosarcoma-cancer and Leukemia Group B experience. Year Published: 1979
5. Clinical and laboratory reevalution of dichloromethotrexate. Year Published: 1981
6. Differences in chemotherapeutic susceptibility of human T-, B-, and non-T-/non-B-lymphocytes in culture. Year Published: 1981
7. Therapeutic effectiveness of neuraminidase-treated allogeneic myeloblasts as immunogen in acute myelocytic leukemia. Year Published: 1982
8. Clinical trial of vinleurosine sulfate (NSC-90636): a new drug derived from Vinca rosea Linn. Year Published: 1966
9. Clinical pharmacologic study of kethoxal bis(thiosemicarbazone) [NSC-82116] in advanced cancer. Year Published: 1967
10. 6-mercaptopurine (NSC-755) given intravenously at weekly intervals to patients with advanced cancer. Year Published: 1968
11. Tryptophan mustard (NSC-62403) in the treatment of acute leukemia and malignant solid tumors in children. Year Published: 1968
12. Effect of vincristine (NSC-67574) on malignant solid tumors in children. Year Published: 1970
13. Treatment of adult leukemia with L-asparaginase (NSC-109229). Year Published: 1972
14. Failure of hydroxyurea (NSC-32065) and prednisone (NSC-10023) in the treatment of acute myelocytic leukemia. Year Published: 1972
15. The chemotherapy of human and animal acute leukemia. Year Published: 1972
16. Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. Year Published: 1973
17. Effects of combination therapy with bleomycin (NSC-125066) and dibromodulcitol (NSC-104800) on squamous cell carcinoma in man. Year Published: 1973
18. Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia. Year Published: 1973
19. Comparison of two dose schedules of dichloromethotrexate (NSC-29630) in lung cancer. Year Published: 1973
20. Cis-diamminedichloroplatinum (NSC-119875): a phase I study. Year Published: 1974
21. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Year Published: 1974
22. Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208). Year Published: 1976
23. Clinical studies of vinblastine. Year Published: 1961
24. Initial clinical study of parenteral methylglyoxal bis(guanylhydrazone) diacetate. Year Published: 1961
25. Combined radiation-chemotherapy for bronchogenic carcinoma--pilot study. Year Published: 1962
26. Initial clinical studies with vincristine. Year Published: 1963
27. COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER. Year Published: 1964
28. CLINICAL STUDY OF O-PHENYLENEDIAMINE (NSC-5354) IN MELANOMA. Year Published: 1965
29. Human liver catalase activity as a prognostic aid in advanced cancer. Year Published: 1962
30. Hypoglycemic effects of methylglyoxal bis (guanylhydrazone) in animals and man. Year Published: 1962
31. Clinical studies with psicofuranine. Year Published: 1960
32. Tolerance to weekly doses of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio]-purine (B.W. 57-323) in humans. Year Published: 1960
33. Breaking the cure barrier 25 years later. Year Published: 2008
Mount Sinai School of Medicine, New York, NY, USA.
34. Breaking the cure barrier 25 years later. Year Published: 2008
Mount Sinai School of Medicine, New York, NY, USA.